Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

432 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Short- and long-term follow-up after fecal microbiota transplantation as treatment for recurrent Clostridioides difficile infection in patients with inflammatory bowel disease.
van Lingen EE, Baunwall SSMD, Lieberknecht SSC, Benech NN, Ianiro GG, Sokol HH, Gasbarrini AA, Cammarota GG, Eriksen MMK, van der Meulen-de Jong AAE, Terveer EEM, Verspaget HHW, Vehreschild MM, Hvas CCL, Keller JJJ. van Lingen EE, et al. Among authors: sokol hh. Therap Adv Gastroenterol. 2023 Mar 8;16:17562848231156285. doi: 10.1177/17562848231156285. eCollection 2023. Therap Adv Gastroenterol. 2023. PMID: 36910163 Free PMC article.
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio.
Benech N, Cassir N, Galperine T, Alric L, Scanzi J, Sokol H; French Fecal Transplant Group. Benech N, et al. Among authors: sokol h. Gastroenterology. 2024 Aug;167(3):627-628. doi: 10.1053/j.gastro.2024.04.022. Epub 2024 Apr 26. Gastroenterology. 2024. PMID: 38679396 No abstract available.
Intratumoral microbiome is driven by metastatic site and associated with immune histopathological parameters: An ancillary study of the SHIVA clinical trial.
Hilmi M, Kamal M, Vacher S, Dupain C, Ibadioune S, Halladjian M, Sablin MP, Marret G, Ajgal ZC, Nijnikoff M, Salomon A, El Beaino Z, Servant N, Dureau S, Sokol H, Nicolle R, Le Tourneau C, Bieche I, Neuzillet C. Hilmi M, et al. Among authors: sokol h. Eur J Cancer. 2023 Apr;183:152-161. doi: 10.1016/j.ejca.2023.01.024. Epub 2023 Feb 8. Eur J Cancer. 2023. PMID: 36868056
Oral tryptophan activates duodenal aryl hydrocarbon receptor in healthy subjects: a crossover randomized controlled trial.
Rueda GH, Causada-Calo N, Borojevic R, Nardelli A, Pinto-Sanchez MI, Constante M, Libertucci J, Mohan V, Langella P, Loonen LMP, Wells JM, Collins SM, Sokol H, Verdu EF, Bercik P. Rueda GH, et al. Among authors: sokol h. Am J Physiol Gastrointest Liver Physiol. 2024 Jun 1;326(6):G687-G696. doi: 10.1152/ajpgi.00306.2023. Epub 2024 Apr 9. Am J Physiol Gastrointest Liver Physiol. 2024. PMID: 38591144 Clinical Trial.
432 results